人参皂苷与生态因子的相关性

环境条件影响中药材活性成分的形成和积累.利用各种数学统计分析方法探讨影响人参皂苷积累的生态因子,提高人参品质.人参样品采自人参道地产区(主产区)吉林、辽宁、黑龙江三省5年生栽培人参,同时采集采样点处的土壤样品.超高效液相(UPLC)色谱法分析了不同产区9种人参皂苷(Rg1、Re、Rf、Rg2、Rb1、Rc、Rb2、Rb3、Rd)的含量;利用“中药材产地适宜性分析地理信息系统”的生态因子空间数据库,获得采样区包括温度、水分、光照等10个生态因子数据;按土壤理化性质常规方法测定土壤样品中的有效硼、有效铁等微量元素和速效氮、速效钾等有效养分.对人参有效成分含量与土壤养分进行典型相关性分析发现,土壤中的有效硼、有效铁、速效氮与人参皂苷含量呈显著正相关,即适当提高土壤中有效硼、有效铁和速效氮的含量可以促进人参皂苷成分的积累,土壤水分与所测人参皂苷含量(Rb3除外)呈显著正相关,速效磷(P)、pH、速效锌(Zn)与各人参皂苷含量呈弱相关;人参皂苷与气候因子相关分析表明,温度(年活动积温、年平均气温、7月最高气温、7月平均气温、1月最低气温、1月平均气温)与人参皂苷含量呈显著负相关,其中与药典中人参含量测定项下的人参皂苷Rg1、Re、Rb1负相关尤为显著(r＞0.6),说明在一定温度范围内,人参皂苷是随着温度的降低而升高的,即适当低温有利于人参皂苷有效成分的积累;海拔与人参皂苷Rc、Rb2、Rb3含量呈显著正相关(r＞0.6),即相对较高的海拔可以促进这3种成分的积累;而年均降水量、年相对湿度和年均日照时数与人参皂苷相关不显著.通过主成分分析(PCA)、典型相关分析、排序等统计方法,考察不同产地样品中人参皂苷含量与生态因子间的相关性,研究结果揭示了温度在人参的主要活性成分-皂苷类形成中起决定性作用,在一定的温度范围内,温度越低越有利于人参皂苷的积累;阐明了土壤中的有效硼、有效铁、速效氮与人参皂苷含量成正相关.研究结果提示在人参实践生产中可以通过适当低温处理,增施硼、铁、氮肥等农艺措施来调控人参皂苷含量.     

基于UPLC法测定离体大鼠及人源肠道菌对三七中人参皂苷代谢的差异

为探究人与大鼠肠道菌群对三七水煎液中三醇型人参皂苷Rg1、Re及二醇型人参皂苷Rb1、Rd体外代谢的差异性及发现其代谢产物原人参二醇PPD与原人参三醇PPT,实验利用UPLC方法测定三七水煎液分别与人、大鼠肠道菌群在厌氧条件下共培养24h后的孵育液中4种皂苷的含量及代谢产物PPD与PPT的含量。结果表明三七中含有三醇型人参皂苷Rg19.4500mg/g、Re1.8872mg/g,二醇型人参皂苷Rb18.5816mg/g、Rd1.9456mg/g。与人源肠道菌共培养后,三七中含有的二醇型、三醇型人参皂苷含量显著降低,重要的是,在培养液中检测到代谢产物PPD和PPT的存在,含量分别为0.2136mg/g及0.0344mg/g,与大鼠肠道菌共培养后,三七中含有的二醇型皂苷含量有轻微降低,而三醇型皂苷含量未见明显变化,但有少量PPT(0.0184mg/g)的生成。由此可见:在体外条件下,三七水煎液中人参皂苷会被人肠道菌群降解生成代谢产物PPD和PPT,而大鼠肠道菌群的降解产物却仅有PPT生成,二者存在种属差异。     

西洋参冠瘿组织培养及其人参皂苷Re和人参皂苷Rg1的产生

考察了培养基组成、培养时间、接种量、pH值、肌醇浓度等对冠瘿组织生长及其人参皂苷含量的影响 ;用HPLC检测了冠瘿组织中人参皂苷Re和人参皂苷Rg1 的含量。高压纸层析电泳证实 ,根癌农杆菌Ti质粒上的T DNA片段已整合进入植物细胞核基因组中。在考察的 6种培养基中 ,White培养基最适合人参皂苷Rg1 的累积(0 0 95 % ) ,MS培养基最适合人参皂苷Re的累积 (0 194 % )。以MS为基本培养基培养 36d、32d时人参皂苷Re和人参皂苷Rg1 累积含量最高 (分别为 0 14 7%和 0 0 6 1% ) ;接种量为 4g、2g (FW flask) ,有利于人参皂苷Re和人参皂苷Rg1的累积 ;培养基pH 5 8时人参皂苷Re含量最高 (0 184 % ) ,培养基pH 5 6时人参皂苷Rg1 累积量最高 (0 0 5 4 % ) ;肌醇浓度为 0 0 5g L时 ,能促进人参皂苷Re合成 (0 182 % ) ,浓度为 0 30g L时 ,有利于人参皂苷Rg1 累积 (0 0 5 5 % )。     

HPLC法同时测定人参皂苷Rb1、Rc、Rd、Rg3、CK和Rh2

目的:建立高效液相色谱法同时测定人参皂苷Rb1、Rc、Rd、Rg3、CK和Rh2的方法.方法:采用ODSC18(4.6 mm×150 mm)色谱柱,流动相乙腈-0.05%磷酸水,梯度洗脱,流速1 Ml/min,检测波长203 nm,柱温35 ℃.结果:人参皂苷Rb1、Rc、Rd、Rg3、CK和Rh2分离效果良好,线性关...     

人参皂苷Rb1对油酸诱导HepG2细胞脂肪堆积的影响作用

通过建立体外肝细胞脂肪堆积模型评价人参皂苷Rb1清除肝细胞脂肪堆积的能力.方法:1 mmol· L-1油酸诱导建立HepG2细胞脂肪堆积模型,从噻唑兰染色吸光度(MTT值)、甘油三酯(TG值)、细胞内脂滴形态3方面评价人参皂苷Rb1的作用.结果:人参皂苷Rb1可明显减轻细胞内脂质堆积现象,显著降低细胞中TG含量,其中100 μg·mL-1人参皂苷Rb1对TG的清除率达37.9％.结论:人参皂苷Rb1具有良好的体外降脂活性,对脂肪肝有较好的预防效果.     

人参皂苷Rb1调节脑微血管NOS/NO改善脑细胞膜通透性

目的:探究人参皂苷Rb1在脂多糖(LPS)诱导的人脑微血管细胞模型中对脑细胞膜通透性的影响。方法:采用噻唑蓝比色法(MTT)及乳酸脱氢酶(LDH)释放检测不同浓度人参皂苷Rb1对LPS刺激人脑微血管内皮细胞系(HBMEC)存活率的影响;采用EVOM法检测HBMEC细胞通透性;采用Griess法、ELISA法及DAF-FM DA荧光探针分别检测NO、ONOO~-含量及eNOS、iNOS活性;Western blot法检测p-eNOS(ser1177)、iNOS蛋白的表达水平。结果:与正常对照组比较,LPS(5μg/m L)可明显降低HBMEC细胞存活率(P0.01);与LPS组比较,随着人参皂苷Rb1浓度的增加细胞存活率明显升高,且中、高剂量组(40、80μmol/L)具有显著性差异(P0.05、P0.01);LPS导致HBMEC单层细胞电阻值明显降低(P0.01),人参皂苷Rb1高剂量组(80μmol/L)可显著抑制LPS所致的细胞膜通透性升高(P0.05);LPS可明显降低HBMEC细胞NO含量(P0.01)升高ONOO~-含量(P0.05),人参皂苷Rb1中、高剂量组(40、80μmol/L)较LPS组具有显著升高NO含量,降低ONOO~-含量的作用(P0.05);与正常对照组比较,LPS组可明显降低HBMEC细胞磷酸化eNOS (ser1177)蛋白的表达水平,而显著升高iNOS蛋白表达水平(P0.01)。人参皂苷Rb1高剂量组(80μmol/L)较LPS组可显著升高p-eNOS(ser1177)蛋白的表达水平,降低iNOS蛋白的表达水平(P0.05)。结论:人参皂苷Rb1可有效降低iNOS活性,升高eNOS活性继而减少NO水平及ONOO~-含量,显著降低LPS导致的脑细胞膜通透性升高。     

三七叶、人参叶和西洋参叶皂苷类成分的研究(英文)

三七叶、人参叶和西洋参叶其皂苷类成分相近,但专属性成分各异,皂苷类成分的分布比例也各不相同。本文建立了HPLC-UV法测定上述皂苷成分的方法,经过方法学考察,各种皂苷成分精密度好、加样回收率高,方法可靠。11种皂苷成分总含量顺序为:西洋参叶>人参叶>三七叶;二醇组皂苷成分含量:西洋参叶>三七叶>人参叶;三醇组皂苷成分含量:人参叶>西洋参叶>三七叶。西洋参叶中二醇组皂苷和人参叶中三醇组皂苷含量明显高于其他。西洋参叶中人参皂苷Rb3和Rd的含量之和占11种皂苷成分的60%以上。鉴于其中人参皂苷的高含量,三七叶、人参叶和西洋参叶应该作为皂苷来源得到充分利用;不同的皂苷成分有不同的药理活性,应基于它们的皂苷组成和比例选择性进行研究和开发。     

外源人参皂苷对人参种子萌发和幼根抗氧化酶活性的影响

研究不同浓度外源人参皂苷(人参总皂苷,人参二醇组皂苷,人参三醇组皂苷, Rb族,Rb3,Re共4种皂苷混合物和两种单体皂苷)对人参种子萌发,幼苗根长、鲜重,幼根中抗氧化酶活性和MDA含量的影响.结果表明:所测试人参皂苷对人参种子萌发、人参幼苗根长生长和幼根鲜重增加均具有抑制化感效应,且抑制程度均随处理浓度的升高而增强;对人参幼根中抗氧化酶活性方面,不同浓度人参总皂苷,人参二醇组皂苷,人参三醇组皂苷处理后,人参根系中SOD,POD和CAT活性均有明显提高,呈现出各酶活性随浓度升高而逐渐增强的效应;人参皂苷Rb族处理后,SOD活性在低中浓度处理时,与对照差别不大,中高浓度处理后低于对照,POD活性在中高浓度处理后显著提高,高浓度处理后活性降幅较大难以恢复到对照水平,CAT活性均低于对照;人参皂苷Rb3处理后,SOD活性均低于对照水平,POD活性在低浓度处理时与对照相当,中高浓度处理后显著低于对照水平,CAT活性逐渐降低,在低中浓度处理时略高于对照,高浓度处理后低于对照水平;人参皂苷Re处理后,SOD和POD活性均显著低于对照.人参幼根中MDA含量均随着处理浓度的增加而升高.     

小型生物反应器内人参不定根的人参皂苷累积

对小型生物反应器(3~10 L)培养人参不定根的生长和人参皂苷(Rg1、Re、Rb1)的累积规律,以及蔗糖浓度、初始接种量对其生长和人参皂苷累积的影响进行研究。结果表明:小型生物反应器内人参不定根的最佳收获周期为7周。初始接种量和蔗糖浓度影响生物反应器内人参不定根的生长和人参皂苷的累积,20或40 g/L蔗糖对人参不定根的生长和人参皂苷的累积优于60 g/L蔗糖;5和10 L生物反应器内最佳初始接种量分别为15和30g,其不定根的生长量分别为9.29和19.17 g,人参皂苷含量分别为5.16和4.58 mg/g。生物反应器内培养7周的人参与栽培4年的人参相比,人参皂苷Rg1和Re含量相差不大,但栽培人参中Rb1的含量远高于生物反应器中所培养的人参不定根。     

蜗牛酶中一种人参皂苷Rb1水解酶的分离纯化

通过DEAE-Sepharose离子交换分段层析,DEAE-Sepharose离子交换梯度层析和SephadexG-100凝胶过滤层析三种方法的联用从中华白玉蜗牛消化酶中分离出一种人参皂苷Rb1水解酶。分离后该酶在SDS-PAGE上呈单一蛋白质务带。应用SDS-PAGE和凝胶过滤层析对分子量的测定,提示该酶是由4个分子量为110～115kD的相同亚基组成的同源四聚体。Rb1为底物的动力学参数Km和Vmax分别为0．790mmol／L和10．192μmol／min／mg。该酶对人参皂苷Rb1糖键进行有选择的水解,可水解人参皂苷Rb1C50位的一个糖苷键生成人参皂苷Rd。     

Role of the ASK1-SEK1-JNK1-HIPK1 signal in Daxx trafficking and ASK1 oligomerization

Overexpression of JNK binding domain inhibited glucose deprivation-induced JNK1 activation, relocalization of Daxx from the nucleus to the cytoplasm, and apoptosis signal-regulating kinase 1 (ASK1) oligomerization in human prostate adenocarcinoma DU-145 cells. However, SB203580, a p38 inhibitor, did not prevent relocalization of Daxx and oligomerization of ASK1 during glucose deprivation. Studies from in vivo labeling and immune complex kinase assay demonstrated that phosphorylation of Daxx occurred during glucose deprivation, and its phosphorylation was mediated through the ASK1-SEK1-JNK1-HIPK1 signal transduction pathway. Data from immunofluorescence staining and protein interaction assay suggest that phosphorylated Daxx may be translocated to the cytoplasm, bind to ASK1, and subsequently lead to ASK1 oligomerization. Mutation of Daxx Ser667 to Ala results in suppression of Daxx relocalization during glucose deprivation, suggesting that Ser667 residue plays an important role in the relocalization of Daxx. Unlike wild-type Daxx, a Daxx deletion mutant (amino acids 501-625) mainly localized to the cytoplasm, where it associated with ASK1, activated JNK1, and induced ASK1 oligomerization without glucose deprivation. Taken together, these results show that glucose deprivation activates the ASK1-SEK1-JNK1-HIPK1 pathway, and the activated HIPK1 is probably involved in the relocalization of Daxx from the nucleus to the cytoplasm. The relocalized Daxx may play an important role in glucose deprivation-induced ASK1 oligomerization.     

DEC1 and MIC-1

Comment on: Qian Y, et al. Proc Natl Acad Sci USA 2012; 109:11300-5.     

LINE-1编码蛋白L1-ORF1的原核表达纯化和多克隆抗体制备

目的: 制备具有肿瘤组织特异性表达的L1-ORF1蛋白多克隆抗体并进行初步应用研究。方法:采取基因工程表达方法制备L1-ORF1蛋白,免疫家兔制备多克隆抗体,间接ELISA检测抗体效价,Western blot和细胞免疫荧光方法检测抗体特异性,免疫检测验证其识别肿瘤细胞内L1-ORF1蛋白的特异性。结果:制备的抗L1-ORF1蛋白多克隆抗体具有很高的敏感性与特异性,免疫学检测表明该抗体不仅能检测出正常细胞中瞬时表达的L1-ORF1蛋白,而且可检测出肿瘤细胞中天然表达的L1-ORF1蛋白。结论:制备的多克隆抗体具有较高的敏感性与特异性,为以后该抗体的进一步应用奠定了基础。     

Antagonism between Cry1Ac1 and Cyt1A1 toxins of bacillus thuringiensis

Most strains of the insecticidal bacterium Bacillus thuringiensis have a combination of different protoxins in their parasporal crystals. Some of the combinations clearly interact synergistically, like the toxins present in B. thuringiensis subsp. israelensis. In this paper we describe a novel joint activity of toxins from different strains of B. thuringiensis. In vitro bioassays in which we used pure, trypsin-activated Cry1Ac1 proteins from B. thuringiensis subsp. kurstaki, Cyt1A1 from B. thuringiensis subsp. israelensis, and Trichoplusia ni BTI-Tn5B1-4 cells revealed contrasting susceptibility characteristics. The 50% lethal concentrations (LC50s) were estimated to be 4,967 of Cry1Ac1 per ml of medium and 11.69 ng of Cyt1A1 per ml of medium. When mixtures of these toxins in different proportions were assayed, eight different LC50s were obtained. All of these LC50s were significantly higher than the expected LC50s of the mixtures. In addition, a series of bioassays were performed with late first-instar larvae of the cabbage looper and pure Cry1Ac1 and Cyt1A1 crystals, as well as two different combinations of the two toxins. The estimated mean LC50 of Cry1Ac1 was 2.46 ng/cm2 of diet, while Cyt1A1 crystals exhibited no toxicity, even at very high concentrations. The estimated mean LC50s of Cry1Ac1 crystals were 15.69 and 19.05 ng per cm2 of diet when these crystals were mixed with 100 and 1,000 ng of Cyt1A1 crystals per cm2 of diet, respectively. These results indicate that there is clear antagonism between the two toxins both in vitro and in vivo. Other joint-action analyses corroborated these results. Although this is the second report of antagonism between B. thuringiensis toxins, our evidence is the first evidence of antagonism between toxins from different subspecies of B. thuringiensis (B. thuringiensis subsp. kurstaki and B. thuringiensis subsp. israelensis) detected both in vivo and in vitro. Some possible explanations for this relationship are discussed.     

Regulation of PCTAIRE1 protein stability by AKT1, LKB1 and BRCA1

PCTAIRE1, also known as CDK16, is a cyclin-dependent kinase that is regulated by cyclin Y. It is a member of the serine-threonine family of kinases and its functions have primarily been implicated in cellular processes like vesicular transport, neuronal growth and development, myogenesis, spermatogenesis and cell proliferation. However, as extensive studies on PCTAIRE1 have not yet been conducted, the signaling pathways for this kinase involved in governing many cellular processes are yet to be elucidated in detail. Here, we report the association of PCTAIRE1 with important cellular proteins involved in major cell signaling pathways, especially cell proliferation. In particular, here we show that PCTAIRE1 interacts with AKT1, a key player of the PI3K signaling pathway that is responsible for promoting cell survival and proliferation. Our studies show that PCTAIRE1 is a substrate of AKT1 that gets stabilized by it. Further, we show that PCTAIRE1 also interacts with and is degraded by LKB1, a kinase that is known to suppress cellular proliferation and also regulate cellular energy metabolism. Moreover, our results show that PCTAIRE1 is also degraded by BRCA1, a well-known tumor suppressor. Together, our studies highlight the regulation of PCTAIRE1 by key players of the major cell signaling pathways involved in regulating cell proliferation, and therefore, provide crucial links that could be explored further to elucidate the mechanistic role of PCTAIRE1 in cell proliferation and tumorigenesis.     

Antagonism between Cry1Ac1 and Cyt1A1 Toxins of Bacillus thuringiensis

Most strains of the insecticidal bacterium Bacillus thuringiensis have a combination of different protoxins in their parasporal crystals. Some of the combinations clearly interact synergistically, like the toxins present in B. thuringiensis subsp. israelensis. In this paper we describe a novel joint activity of toxins from different strains of B. thuringiensis. In vitro bioassays in which we used pure, trypsin-activated Cry1Ac1 proteins from B. thuringiensis subsp. kurstaki, Cyt1A1 from B. thuringiensis subsp. israelensis, and Trichoplusia ni BTI-Tn5B1-4 cells revealed contrasting susceptibility characteristics. The 50% lethal concentrations (LC₅₀s) were estimated to be 4,967 of Cry1Ac1 per ml of medium and 11.69 ng of Cyt1A1 per ml of medium. When mixtures of these toxins in different proportions were assayed, eight different LC₅₀s were obtained. All of these LC₅₀s were significantly higher than the expected LC₅₀s of the mixtures. In addition, a series of bioassays were performed with late first-instar larvae of the cabbage looper and pure Cry1Ac1 and Cyt1A1 crystals, as well as two different combinations of the two toxins. The estimated mean LC₅₀ of Cry1Ac1 was 2.46 ng/cm² of diet, while Cyt1A1 crystals exhibited no toxicity, even at very high concentrations. The estimated mean LC₅₀s of Cry1Ac1 crystals were 15.69 and 19.05 ng per cm² of diet when these crystals were mixed with 100 and 1,000 ng of Cyt1A1 crystals per cm² of diet, respectively. These results indicate that there is clear antagonism between the two toxins both in vitro and in vivo. Other joint-action analyses corroborated these results. Although this is the second report of antagonism between B. thuringiensis toxins, our evidence is the first evidence of antagonism between toxins from different subspecies of B. thuringiensis (B. thuringiensis subsp. kurstaki and B. thuringiensis subsp. israelensis) detected both in vivo and in vitro. Some possible explanations for this relationship are discussed.     

Generation of 'humanized' hCYP1A1_1A2_Cyp1a1/1a2(-/-) mouse line

Human/rodent CYP1A1 and CYP1A2 orthologs are well known to exhibit species-specific differences in substrate preferences and rates of metabolism. This lab previously characterized a BAC-transgenic mouse carrying the human CYP1A1_CYP1A2 locus; in this line, human dioxin-inducible CYP1A1 and basal vs dioxin-inducible CYP1A2 have been shown to be expressed normally (with regard to mRNAs, proteins and three enzyme activities) in every one of nine mouse tissues studied. The mouse Cyp1a1 and Cyp1a2 genes are oriented head-to-head and share a bidirectional promoter region of 13,954 bp. Using Cre recombinase and loxP sites inserted 3' of the stop codons of both genes, we show here a successful interchromosomal excision of 26,173 bp that ablated both genes on the same allele. The Cyp1a1/1a2(-) double-knockout allele was bred with the "humanized" line; the final product is the hCYP1A1_1A2_Cyp1a1/1a2(-/-) line on a theoretically >99.8% C57BL/6J genetic background-having both human genes replacing the mouse orthologs. This line will be valuable for human risk assessment studies involving any environmental toxicant or drug that is a substrate for CYP1A1 or CYP1A2.     

Isolation and Characterization of Ubiquitin-activating Enzyme E1-domain Containing 1, UBE1DC1

Ubiquitin and other ubiquitin-like proteins play important roles in post-translational modification. They are phylogenetically well-conserved in eukaryotes. Activated by other proteins, ubiquitin and ubiquitin-like proteins can covalently modify target proteins. The enzymes responsible for the activation of this modification have been known to include UBA1, SAE2, UBA3, SAE1 and ULA1. Here we report a new ubiquitin activating enzyme like cDNA, named ubiquitin activating enzyme E1-domain containing 1 (UBE1DC1), whose cDNA is 2654 base pairs in length and contains an open reading frame encoding 404 amino acids. The UBE1DC1 gene consists of 12 exons and is located at human chromosome 3q22. The result of RT-PCR showed that UBE1DC1 is expressed in most of human tissues. These two authors contributed equally to this paper. The nucleotide sequence reported in this paper has been submitted to GenBank under accession number AY253672.